Largest Denmark Life Science Add-on Transactions

Founded in 2000, Arrow Group is a global generic pharmaceutical company. With commercial operations in over 20 countries, Arrow's geographic reach comprises a mix of established, growing and emerging markets worldwide. The company operates as Arrow Generics in the United Kingdom, as Cobalt Pharmaceuticals in the U.S. and Canada and as Arrow Generiques in France. Arrow also manages strategically located production facilities in Brazil, Canada and Malta, and employs 250 at its Australia-based R&D facility.

Allergan
Company
Life Science
Parsippany, New Jersey
www.allergan.com

Fertin develops and manufactures pharmaceutical and nutraceutical products for leading global companies to support healthier living. Fertin’s product portfolio has a broad variety of current and possible application areas including Nicotine Replacement Therapy, oral care, gastrointestinal, pain and allergy management, cough and cold, and much more. Fertin was founded in 1915 and is based in Vejle, Denmark.

Philip Morris International
Company
Consumer Products
Stamford, Connecticut
www.pmi.com

EQT
Investor
Private Equity Firm
Stockholm, Sweden
www.eqtgroup.com
Advisors: Accura , PwC Corporate Finance , FIH Partners

Bagger-Sorensen Group
Company
Consumer Products
Vejle, Denmark

AGC Biologics is a global contract manufacturing and development (CDMO) company for biopharmaceuticals. AGC Biologics is based in Bothell, Washington.

AGC
Company
Manufacturing
Chiyoda-ku, Japan
www.agc.com

Monitor Clipper Partners
Investor
Private Equity Firm
Boston, Massachusetts
www.monitorclipper.com

EEP Advisers
Investor
Venture Capital Firm
London, United Kingdom
www.eeplp.com

Santaris Pharma A/S is developing a diverse pipeline of LNA therapeutics that influence the production or activity of select RNA targets to address diseases that are difficult-to-treat with conventional drug modalities. Santaris uses its proprietary Locked Nucleic Acid (LNA) platform and tissue-targeting expertise to pioneer next-generation antisense product candidates.

Roche
Company
Life Science
Basel, Switzerland
www.roche.com

Gilde Healthcare
Investor
Private Equity Firm
Utrecht, Netherlands
www.gildehealthcare.com

VetXX markets pharmaceutical products for skin, eye and ear diseases, produces pet diet food (through the brand SPECIFIC) and pet care products for companion animals. All animal health products are distributed exclusively through veterinary surgeries.

Dechra Pharmaceuticals
Company
Life Science
Northwich, United Kingdom
www.dechra.com

Montagu
Investor
Private Equity Firm
London, United Kingdom
www.montagu.com

Epitherapeutics ApS is a developer of novel innovative cancer drugs based on epigenetics.

Gilead Sciences
Company
Life Science
Foster City, California
www.gilead.com

Azanta A/S is a privately-owned specialty pharma company primarily operating within oncology, women's health and addiction medicine. Azanta A/S currently markets (or makes available under special authorization) a portfolio of specialty pharmaceutical products, including Nimorazole a hypoxic radiosensitizer for the treatment of head and neck cancer patients undergoing primary radiotherapy and Angusta® for labor induction.

Norgine
Company
Life Science
Amsterdam, Netherlands
www.norgine.com

EEP Advisers
Investor
Venture Capital Firm
London, United Kingdom
www.eeplp.com

Symphogen AS is a polyclonal antibody technology that provides a totally new, innovative class of biopharmaceuticals for treating serious human diseases. Symphogen was founded in 2000 and is based in Ballerup, Denmark.

Servier
Company
Life Science
Suresnes, France
www.servier.com

EW Healthcare Partners
Investor
Growth Capital Firm
New York, New York
www.ewhealthcare.com

Gilde Healthcare
Investor
Private Equity Firm
Utrecht, Netherlands
www.gildehealthcare.com

AROS Applied Biotechnology, a provider of genomic solutions in Europe, serving the pharmaceutical industry, as well as academic and public research institutes.

Eurofins Scientific
Company
Life Science
Luxembourg, Luxembourg
www.eurofins.com

Serendex Pharmaceuticals A/S is a developer of novel inhalation therapies for the treatment of patients with rare respiratory conditions.

Savara Pharmaceuticals
Company
Life Science
Austin, Texas
www.savarapharma.com

Contera Pharma ApS is involved in identifying and developing treatments for patients suffering from movement disorders.

Bukwang Pharmaceutical
Company
Life Science
Seoul, South Korea
www.bukwang.co.kr

NordMedica A/S holds the worldwide licence for the product Amsidine, currently marketed under the trademarks Amekrin®, Amsidine® and Amsidyl®. Amsidine is a chemotherapeutic drug with the active ingredient Amsacrine. It has a solid reputation and is used for the treatment of Acute Myeloid Leukaemia (AML) and Acute Lymphatic Leukaemia (ALL).

Eurocept
Company
Life Science
Houten, Netherlands
www.eurocept.nl

VBM Laboratoriet A/S is a developer of an environment testing laboratories in the country, with a strong reputation for testing of contaminated soil and building materials particularly within the construction sector.

Eurofins Scientific
Company
Life Science
Luxembourg, Luxembourg
www.eurofins.com

Galecto is a clinical-stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets that are at the heart of fibrosis, inflammation, and cancer. Galecto was formed in 2011 and is based in Copenhagen, Denmark.

Bristol-Myers Squibb
Company
Life Science
Princeton, New Jersey
www.bms.com

GEA Pharmaceutical A/S is a developer of solid finished dosage forms.

Axplora
Company
Life Science
Raubling, Germany
www.axplora.com

Zymenex A/S is a biopharmaceutical group focused on research and development of innovative biologic therapeutics for the treatment of rare and life threatening genetic diseases.

Chiesi Farmaceutici S.p.A
Company
Life Science
Parma, Italy
www.chiesigroup.com